Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Stephan Schaller, Ph.D.
CEO and Founder
ESQlabs GmbH, Germany
Poster(s):
(M1430-05-27) Integration of a Novel First-Order Release Z-Factor Dissolution Model with Global Sensitivity Analysis to Guide Formulation Development Using Physiologically-Based Biopharmaceutics in OSPSuite v12
Monday, November 10, 2025
2:30 PM - 3:30 PM
CT
